SPECIAL NOTICE
68 -- Contract for oral rabies vaccine - ONRABŪ Ultralite baits
- Notice Date
- 4/10/2015
- Notice Type
- Special Notice
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Agriculture, Animal and Plant Health Inspection Service, Administrative Services Division/Contracting, 100 North 6TH Street, Butler Square 5TH Floor, Minneapolis, Minnesota, 55403
- ZIP Code
- 55403
- Solicitation Number
- PR-15-739942
- Archive Date
- 5/29/2015
- Point of Contact
- Carol R. Dingess, Phone: 970-494-7360, Patricia Simon, Phone: 612-336-3460
- E-Mail Address
-
carol.dingess@aphis.usda.gov, Patricia.M.Simon@aphis.usda.gov
(carol.dingess@aphis.usda.gov, Patricia.M.Simon@aphis.usda.gov)
- Small Business Set-Aside
- N/A
- Description
- The United States Department of Agriculture (USDA)/Animal Plant Health Inspection Service (APHIS)/Wildlife Services, National Rabies Management Program in Concord, NH intends to award a sole source, 2-year contract to Artemis Technologies, LLC (DUNS: 179190116 CAGE Code: 4TKA0) for the supply of the oral rabies vaccine ONRAB® Ultralite baits. Wildlife Services proposes to purchase up to 1,800,000 (500 boxes) units of the Ultralite bait containing the oral rabies vaccine ONRAB® during 2015 and up to 2,000,000 units (556 boxes) during 2016. This procurement is being conducted in accordance with FAR 6.302-1 Authority. Citation: 41 U.S.C. 3304(a)(1). The property or services needed are available from only one responsible qualified source at this time and no other type of property or services will satisfy these needs. USDA, APHIS, Wildlife Services (WS) and state and federal collaborators conducted field trials during 2011-2014 to evaluate the safety and efficacy of a human adenovirus type 5-rabies glycoprotein recombinant (AdRG1.3) ONRAB® rabies vaccine in raccoons and striped skunks. To date, Raboral V-RG® (a vaccinia-rabies glycoprotein recombinant oral rabies vaccine), the only oral rabies vaccine licensed for use in the United States to control rabies in raccoons and coyotes, has been the only oral rabies vaccine used operationally in rabies control campaigns. This vaccine has allowed WS and cooperators to prevent raccoon rabies from spreading appreciably, but achieving elimination of raccoon rabies is expected to require higher levels of rabies antibody seroconversion in raccoon populations targeted for oral vaccination at currently used bait densities. In addition, there is a need to also orally vaccinate skunks as raccoon rabies often spills over into the skunk population, a potential source of re-infection in raccoons. ONRAB® has been identified as a candidate for testing, in part, because this oral vaccine demonstrated higher levels of rabies antibody seroconversion in raccoons than the oral vaccine currently in use in the United States in two cross border comparison studies. In addition, it has produced favorable control in raccoons and, in some cases, skunks in Canada. Although the recombinant ONRAB® vaccine has been used extensively in southern Ontario since 2006 and Quebec since 2007 with good reported success, these field trials represented the first release of this vaccine into the field in the United States. The Act of March 2, 1931 (7 U.S.C. 426-426b and 426c), as amended, provides the Secretary of Agriculture authority to conduct and cooperate in rabies control in wildlife. Rabies is one of the oldest recorded mammalian diseases. All mammals, including humans, are susceptible or rabies. Rabies is almost always transmitted by the bite of a rabid animal, usually a carnivore or insectivorous bat. If humans do not receive timely post-exposure treatment, rabies is fatal. Ready access to treatment, integrated with public health education, and pet vaccination programs, has effectively kept the annual human death rate near zero in the U.S. and other developed countries. Worldwide, however, the human mortality rate from rabies is estimated at 55,000 to 70,000 annually. Post exposure treatment is not available for animals; consequently, animals infected with rabies typically bite or attempt to bite other animals when the disease becomes clinical, often transmitting the fatal virus before they die. Before 1960, the majority of positive rabies cases were reported in dogs. The combination of public education and pet vaccination programs, however, has effectively controlled rabies in companion animals. By the early 1960's wildlife surpassed the dog in reported rabies cases. The principal rabies reservoirs are wild carnivores (raccoon, skunks, foxes, coyote; and the mongoose in Puerto Rico) and bats that have, for the past decade, accounted for 90% or greater of all positive rabies cases reported in animals in the United States and Puerto Rico. Varying ecological, behavioral and biological attributes of diverse carnivore and bat vectors introduce new challenges to contemporary rabies control programs that underscore the need for interdisciplinary collaboration among wildlife professionals, veterinarians, physicians, public affairs specialists, environmental compliance experts, economists, and others. ORV targeting rabies in red foxes began in Europe in 1977, with several countries now classified as rabies free from coordinated campaigns, while others continue to conduct ORV with the goal of rabies elimination. ORV was initiated in Ontario, Canada in 1989, where fox rabies and raccoon rabies have nearly been eliminated through strategic use of this technology. In 1998, USDA, APHIS, Wildlife Services initiated a national cooperative ORV program, which expanded to include 17 states by 2007 and now includes 15 states in 2015. ORV zones were integrated with natural geographic features such as large lakes, rivers and poorer raccoon habitats at high elevations where practical to bolster vaccination barriers and reduce the overall cost of rabies control. ORV was implemented to eliminate canine rabies (spread predominantly by coyotes) from south Texas. This goal was achieved in 2000, but a 65-km wide maintenance vaccination barrier has been created along the Rio Grande to prevent re-infection from Mexico. The containment barrier for gray fox rabies that was created in 1996 in west-central Texas has been collapsed with the goal of elimination over the next 4-5 years. Much of the remaining effort is to contain raccoon rabies that occurs from southwest Alabama to Maine from spreading to new areas, while exploring elimination strategies. This Notice of Intent is not a request for competitive proposals. No solicitation documents are available and telephone requests will not be honored. However, if a firm believes it can meet the requirements it must furnish information about its products and services to the Contract Specialist listed on this notice by 4:00pm. Mountain Time (MT) on the closing date of this notice. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. The North American Industry Classification System (NAICS) code for this acquisition is 325414 - Biological Product (except Diagnostic) Manufacturing, and the Small business size standard is 500 Employees. Responses received after the response date or without the required information will be deemed nonresponsive to the synopsis and will not be considered. Capability statements may be sent to: Carol Dingess, Contracting Officer, USDA-APHIS-MRPBS, AAMD Procurement Branch, 2150 Centre Avenue Building B MS (2E20) Fort Collins, CO 80526, or via email @ Carol.Dingess@aphis.usda.gov or fax @ 970-472-1897.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USDA/APHIS/Contracting/PR-15-739942/listing.html)
- Place of Performance
- Address: National Rabies Management Program, 59 Chenell Dr., Ste. 2, Concord, New Hampshire, 03301, United States
- Zip Code: 03301
- Zip Code: 03301
- Record
- SN03696476-W 20150412/150410234837-a4a2da8546d3068cd4652018389801a6 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |